BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 14530210)

  • 1. Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice.
    David DJ; Bourin M; Jego G; Przybylski C; Jolliet P; Gardier AM
    Br J Pharmacol; 2003 Nov; 140(6):1128-36. PubMed ID: 14530210
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of substance P (neurokinin 1) receptors enhances extracellular serotonin when combined with a selective serotonin reuptake inhibitor: an in vivo microdialysis study in mice.
    Guiard BP; Przybylski C; Guilloux JP; Seif I; Froger N; De Felipe C; Hunt SP; Lanfumey L; Gardier AM
    J Neurochem; 2004 Apr; 89(1):54-63. PubMed ID: 15030389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blockade of the high-affinity noradrenaline transporter (NET) by the selective 5-HT reuptake inhibitor escitalopram: an in vivo microdialysis study in mice.
    Nguyen HT; Guiard BP; Bacq A; David DJ; David I; Quesseveur G; Gautron S; Sanchez C; Gardier AM
    Br J Pharmacol; 2013 Jan; 168(1):103-16. PubMed ID: 22233336
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of antidepressants on norepinephrine and serotonin concentrations in the rat frontal cortex: an in-vivo microdialysis study.
    Beyer CE; Boikess S; Luo B; Dawson LA
    J Psychopharmacol; 2002 Dec; 16(4):297-304. PubMed ID: 12503828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allosteric modulation of the effect of escitalopram, paroxetine and fluoxetine: in-vitro and in-vivo studies.
    Mansari ME; Wiborg O; Mnie-Filali O; Benturquia N; Sánchez C; Haddjeri N
    Int J Neuropsychopharmacol; 2007 Feb; 10(1):31-40. PubMed ID: 16448580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of selective serotonin and serotonin/noradrenaline reuptake inhibitors on extracellular serotonin in rat diencephalon and frontal cortex.
    Felton TM; Kang TB; Hjorth S; Auerbach SB
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Mar; 367(3):297-305. PubMed ID: 12644903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blockade of 5-hydroxytryptamine and noradrenaline uptake by venlafaxine: a comparative study with paroxetine and desipramine.
    Béïque JC; de Montigny C; Blier P; Debonnel G
    Br J Pharmacol; 1998 Oct; 125(3):526-32. PubMed ID: 9806336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of acute and chronic tianeptine administration on serotonin outflow in rats: comparison with paroxetine by using in vivo microdialysis.
    Malagié I; Deslandes A; Gardier AM
    Eur J Pharmacol; 2000 Sep; 403(1-2):55-65. PubMed ID: 10969144
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reciprocal effects of combined administration of serotonin, noradrenaline and dopamine reuptake inhibitors on serotonin and dopamine levels in the rat prefrontal cortex: the role of 5-HT1A receptors.
    Weikop P; Kehr J; Scheel-Krüger J
    J Psychopharmacol; 2007 Nov; 21(8):795-804. PubMed ID: 17984160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of venlafaxine on extracellular concentrations of 5-HT and noradrenaline in the rat frontal cortex: augmentation via 5-HT1A receptor antagonism.
    Dawson LA; Nguyen HQ; Geiger A
    Neuropharmacology; 1999 Aug; 38(8):1153-63. PubMed ID: 10462128
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of 5-HT1A receptors by (+/-)-pindolol potentiates cortical 5-HT outflow, but not antidepressant-like activity of paroxetine: microdialysis and behavioral approaches in 5-HT1A receptor knockout mice.
    Guilloux JP; David DJ; Guiard BP; Chenu F; Repérant C; Toth M; Bourin M; Gardier AM
    Neuropsychopharmacology; 2006 Oct; 31(10):2162-72. PubMed ID: 16452992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Potency of Venlafaxine, Paroxetine, and Atomoxetine to Inhibit Serotonin and Norepinephrine Reuptake in Patients With Major Depressive Disorder.
    Aldosary F; Norris S; Tremblay P; James JS; Ritchie JC; Blier P
    Int J Neuropsychopharmacol; 2022 Apr; 25(4):283-292. PubMed ID: 34958348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of chronic paroxetine treatment on dialysate serotonin in 5-HT1B receptor knockout mice.
    Gardier AM; David DJ; Jego G; Przybylski C; Jacquot C; Durier S; Gruwez B; Douvier E; Beauverie P; Poisson N; Hen R; Bourin M
    J Neurochem; 2003 Jul; 86(1):13-24. PubMed ID: 12807420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of acute treatment with YM992 on extracellular norepinephrine levels in the rat frontal cortex.
    Hatanaka K; Yatsugi S; Yamaguchi T
    Eur J Pharmacol; 2000 Apr; 395(1):31-6. PubMed ID: 10781670
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 5-HT1B Autoreceptors limit the effects of selective serotonin re-uptake inhibitors in mouse hippocampus and frontal cortex.
    Malagié I; Trillat AC; Bourin M; Jacquot C; Hen R; Gardier AM
    J Neurochem; 2001 Feb; 76(3):865-71. PubMed ID: 11158258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [5-HT1B serotonin receptors and antidepressant effects of selective serotonin reuptake inhibitors ].
    Gardier AM; Trillat AC; Malagié I; David D; Hascoët M; Colombel MC; Jolliet P; Jacquot C; Hen R; Bourin M
    C R Acad Sci III; 2001 May; 324(5):433-41. PubMed ID: 11417564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
    Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
    Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of different challenge doses after repeated citalopram treatment on extracellular serotonin level in the medial prefrontal cortex: in vivo microdialysis study.
    Muraki I; Inoue T; Hashimoto S; Izumi T; Koyama T
    Psychiatry Clin Neurosci; 2008 Oct; 62(5):568-74. PubMed ID: 18950377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of hyperlocomotion in mice exposed to a novel environment by inhibition of serotonin reuptake. A pharmacological characterization of diverse classes of antidepressant agents.
    Brocco M; Dekeyne A; Veiga S; Girardon S; Millan MJ
    Pharmacol Biochem Behav; 2002 Apr; 71(4):667-80. PubMed ID: 11888558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tramadol increases extracellular levels of serotonin and noradrenaline as measured by in vivo microdialysis in the ventral hippocampus of freely-moving rats.
    Bloms-Funke P; Dremencov E; Cremers TI; Tzschentke TM
    Neurosci Lett; 2011 Mar; 490(3):191-5. PubMed ID: 21195741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.